Pancreatic Cancer Vaccine: Cancer is a serious problem, on hearing about which a person breaks down from within. If we talk about pancreatic cancer, then it is a very serious and fast growing cancer which occurs in the pancreas. Pancreas is an organ of the body that plays an important role in producing digestive enzymes and hormones like insulin. This cancer is often not detected in its early stages because the pancreas is located deep in the body and its symptoms may initially be general or vague, such as stomach pain, weight loss or digestive problems, which may not seem so serious. By the time it is detected, in many cases it has spread to other parts of the body, making its treatment even more difficult.

For this reason, it is counted among the most dangerous and deadly cancers. According to statistics, the incidence of pancreatic cancer has doubled in the last two decades. Earlier it was about 2.5 to 3 out of 1000000 persons, now it has increased to 6 to 7. Recently, the trial of a vaccine for the treatment of this cancer has become possible, which has given a new direction in its treatment, know the whole thing.

What is mRNA vaccine to treat pancreatic cancer?

Recently, the trial of a vaccine named Autogene Sevumaran has raised a new hope in the treatment of pancreatic cancer. This is a personalized vaccine that is prepared based on the genetic information (neoantigens) of the patient’s tumor and signals the body’s immune system to recognize and destroy cancer cells. According to the researchers, it is based on mRNA technology – a technology based on messenger ribo-nucleic acid (mRNA) that is used for treatment, not for reducing the risk of disease. This vaccine is given after surgery so that the microscopic cancer cells remaining in the body can be eliminated and the risk of cancer recurring can be reduced.

Also read: Heatstroke Symptoms: The body starts making gestures even before heatstroke, how to identify them?

Results of clinical trials – how much success was achieved

Talking about the results of clinical trials, in the Phase-1 study, a total of 16 patients were given Autogene Sevumaran vaccine after pancreatic cancer surgery. Along with this, chemotherapy and an immunotherapy drug (checkpoint inhibitor) were also given to the patients. The vaccine was prepared individually according to the DNA of each patient’s tumor. The vaccine had a good effect in 8 out of these 16 patients. Their body’s immune system recognized the tumor and started producing T-cells that attack the cancer cells. Out of 8 patients, 7 remained alive even 4 to 6 years after surgery. On the other hand, out of the 8 patients in whom the vaccine did not respond, only 2 remained alive. After these good initial results, now Phase-2 clinical trial of this vaccine has been started, in which it is being tested on more patients. This study is going on at many other places including MSK (Memorial Sloan Kettering) in New York, so that its effect and safety can be understood better.

mRNA vaccine has emerged as a great hope for the treatment of pancreatic cancer. Although its Phase-2 has just started, but it is being considered a big achievement in the field of medical science. Researchers believe that if similar results are obtained in Phase-2 and Phase-3, then it can bring revolutionary changes in the medical field.

Also read: World Malaria Day: Ignoring mild fever can be serious, it can lead to malaria.

Check out below Health Tools-
Calculate Your Body Mass Index (BMI)

Calculate The Age Through Age Calculator

Check out below Health Tools-
Calculate Your Body Mass Index (BMI)

Calculate The Age Through Age Calculator

Russia has claimed to have achieved great success against a deadly disease like cancer. Scientists there have prepared a new MRNA-based cancer vaccine “Enteromix”, which has shown 100 percent effective results in early pre-clinical trials. It is being claimed that this vaccine may change the direction of treating cancer in the coming time. Currently, it is being prepared for trial on humans. Let us tell you about it.

Why is this discovery special?

Cancer is one of the biggest causes of death worldwide. According to WHO, every year about 1 crore people lose their lives from cancer. So far, treatment such as chemotherapy and radiation damages not only cancer cells but also healthy cells. At the same time, this new Russian vaccine makes the body’s immunity so strong that it only attacks cancer cells.

How does the vaccine work?

Enteromix is ​​a personalized MRNA vaccine. That is, it is made on the basis of genetic information of every patient’s tumor. AI technology is used in this. Scientists can design the patient according to the patient in a few hours. This vaccine “trains” the body’s immune system so that it can recognize cancer cells and eliminate them.

How are the initial results?

According to Sputnik, the Federal Medical and Biological Agency (FMBA) has announced that it has been successful in MRNA-based vaccine pre-clinical trials. The agency’s chief Veronica Squortsova said that the vaccine has shown not only security but also effectiveness. The report states that this vaccine has given significant results in shortening the tumor and slowing their growth. The most important thing is that it is also considered safe for repeated use. Squortsova further stated that this vaccine will be prepared differently for every patient and it will be customized on the basis of their RNA profile. The first variant of this vaccine will be used to treat colorectal cancer. In addition, the second variant is being developed for glioblastoma (brain cancer) and certain types of melanoma (skin cancer).

St. Petersburg International Economic Forum (Spief 2025), which took place from 18 to 21 June in St. Petersburg, the northern city of Russia, while the clinical trial of this vaccine was announced. The event was organized by the Roskongres agency under the Russian President’s office, showing the progress in Russia’s medical research and biotechnology.

According to the report of the presspath, the entrance vaccine uses four safe viruses, which destroy them by directly attacking cancer tumors and also strengthens the immune system, so that the body itself can fight the disease. This vaccine has proved to be very effective after the tests conducted for many years. The report states that it has slowed the growth of cancer tumors and in some cases even the tumor has completely eliminated. Now that the trials are successfully completed, only regulatory approval (government approval) remains. If it is approved, the entrances can become the world’s first personalized MRNA cancer vaccine, which will be available to the common people.

Success rate and challenges

In reports, the success rate of the vaccine is said to be 100 percent, but experts say that this is just the initial results. The real impact will be detected only after trial on humans. Therefore, it is too early to call it a “final treatment” of cancer. The Russian government has said that after the trial is successful, this vaccine will be given free to citizens. However, the estimated price of one of its doses is said to be around 24–25 thousand rupees (300,000 rubles). Russia’s new MRNA cancer vaccine can prove to be a major change for Enteromix Medical Science. If it is equally effective on humans, then it can become a game-changer in the treatment of cancer. The whole world’s eyes are on the trials to be held in the coming months.

Also read: If these 7 problems happen, then all the hair of the skull will come in hand, women have more problems

Disclaimer: This information is based on the opinion of research studies and experts. Do not consider it an alternative to medical advice. Before adopting any new activity or exercise, consult your doctor or concerned specialist.

Check out Below Health Tools-
Calculate your body mass index (BMI)

Calculate the age through age calculator